Ad is loading...
FEQTX
Price
$31.03
Change
-$0.10 (-0.32%)
Updated
Nov 15 closing price
VIVAX
Price
$68.72
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

FEQTX vs VIVAX

Header iconFEQTX vs VIVAX Comparison
Open Charts FEQTX vs VIVAXBanner chart's image
Fidelity Equity Dividend Income
Price$31.03
Change-$0.10 (-0.32%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.72
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
FEQTX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FEQTX vs. VIVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEQTX is a StrongSell and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. FEQTX (6.12B). FEQTX (2.34) and VIVAX (2.25) have matching dividends . FEQTX was incepted earlier than VIVAX: FEQTX (34 years) vs VIVAX (32 years). FEQTX is a more actively managed with annual turnover of: 45.00 vs. VIVAX (10.00). FEQTX has a lower initial minimum investment than VIVAX: FEQTX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 25.55 vs. FEQTX (21.86). VIVAX return over 5 years is better than : 50.81 vs. FEQTX (31.15).
FEQTXVIVAXFEQTX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence34 years32 years-
Gain YTD16.30017.91291%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.12B184B3%
Annual Yield % from dividends2.342.25104%
Returns for 1 year21.8625.5586%
Returns for 3 years10.2821.5848%
Returns for 5 years31.1550.8161%
Returns for 10 years29.70110.4627%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LI22.720.49
+2.20%
Li Auto
ICCC3.610.01
+0.28%
ImmuCell Corp
BXC120.39-0.95
-0.78%
BlueLinx Holdings
LNTH76.83-4.01
-4.96%
Lantheus Holdings
PSTX2.76-0.45
-14.02%
Poseida Therapeutics